Pharmaceutical industry overview: Global outlook While the US and Europe are the frontrunners in the global pharmaceutical market, total prescription drug sales worldwide are … Pharmaceutical Industry 10 Years Future Outlook—Opportunity! One of the first examples of this new landscape starting to emerge was of course Google’s parent company Alphabet founding Verily Life Sciences in November 2018. The most striking thing is that M&A in the pharma industry remained vibrant throughout 2019 despite a global downturn across most other sectors. Tweet. Michael Jewell, partner and head of healthcare & life sciences at Cavendish Corporate Finance looks back at the key trends across pharma industry funding in 2019 and gives his perspective on how 2020 will look. Strategically, Big Pharma will not invest in something that may never progress to the next stage. At the same time, smaller and mid-cap firms continue to be snapped up for their innovative abilities. PharmaBoardroom provides industry trends, [2] This was already a defining characteristic in 2018, when we saw a series of mega-deals including Takeda’s GBP 64bn purchase of Shire, catapulting Takeda into the global top 10 pharmaceutical firms by revenue. global markets. It provides an outlook of the pharmaceutical … The first has undoubtedly been a number of very large transactions between the industry’s biggest companies, with firms consolidating to elevate their position in a highly competitive market. This is consistent with the industry's distribution of outlooks and CreditWatch placements of 31% negative and 7% positive as of … Pharmaceutical industry in the United Kingdom (UK), Pharmaceutical industry in the Netherlands, United States biopharmaceutical market 2020, Over-the-counter medicine industry in the United Kingdom, Pharmaceutical market: worldwide revenue 2001-2019, World pharmaceutical market CAGR forecast by region group 2020-2024, R&D expenditure in the pharmaceutical industry in Spain 2009-2019, Market value of pharmaceutical industry by European country 2018, World pharmaceutical market distribution by submarket 2014-2019, Find your information in our database containing over 20,000 reports, Tools and Tutorials explained in our Media Centre, Unlimited access to statistics, Market Outlooks and forecasts. The best of times Let’s start with the good news: … Expanding Biosimilar Markets Due to Biologic Patent Expirations. Only at DCAT Week can you and your team get a comprehensive market assessment with the information you need to know to help guide your decision … Pharmaceutical Industry Biopharmaceutical Industry Based on Service Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in … This is certainly something which is focusing the minds of many pharma company Board members. The most striking thing is that M&A in the pharma industry remained vibrant throughout 2019 despite a global downturn across most other sectors. Shuchi.P.Nahar The pharmaceutical sector is at a crossroads. Protel tracks capex project activity across the main process sectors to help suppliers win new business. It provides an outlook of the pharmaceutical and biotechnology market in 2020, with focus especially on companies and products. However, recent pressure to address drug prices from US lawmakers on both sides of the aisle, including a number of US state legislatures, has meant that this tactic is likely to return less revenue in years to come, forcing executives to turn to innovation M&A to add high revenue yielding drugs to their portfolios. New, Everything you need to know about the industry development, Find studies from all around the internet. However, there are signs of positivity. Though not directly moving into pharma yet, ventures have included health-tech initiatives like AI product Google Brain to assist physicians during check-ups, partnering with y Gilead to study immunological disorders, and also with GSK to found Galvani Bioelectronics to research, develop and market new bioelectric medicines. M&A volumes have been steadily increasing over the past few years, and all of the fundamentals are in place for this to continue at its current ~10 percent growth rate. This is of course explained by the fact that early-stage drug development requires considerable investment for what is often a low probability of success. And whilst the impact that Big Tech will have in healthcare remains to be seen, the pace of deal making in the pharma sector is likely to remain brisk in 2020. An Outlook for 2020 All of which brings us to the he outlook for M&A in 2020, which in my view is already looking strong. Indeed, former Teva chairman Dr Titzhak Peterburg stated in back in 2017 that “…a good part of our competitors are not only the Novartis’s of the world and the other pharmas but really the Amazons and the Googles.”[3]. However, late-stage trials also require high level investment and crucially the ability to navigate complex regulatory pathways – capabilities that larger pharma companies do have. The relentless need to maintain a competitive edge in the market by acquiring other firm’s portfolios, driven by pressures to innovate and seek new revenue streams, means that M&A will certainly remain a key tactic of Big Pharma for the foreseeable future. It’s worth looking at all these factors in more detail. Directly accessible data for 170 industries from 50 countries This report was published by EP Vantage and EvaluatePharma at year-end 2019. In a … The European market should continue to mature while the US offers opportunities, albeit with practical challenges. PM News . The outlook has never seemed more promising – or more ominous. The pharmaceutical and biotechnology sectors are at a decisive moment. The pharmaceutical manufacturing industry is the one that is growing day by day due to the ever-increasing demand in its services. Use of Artificial Intelligence. Yet research carried out by McKinsey has shown that the share of revenues in the sector coming from innovations sourced outside of Big Pharma has grown from around 25 percent in 2001 to nearly 50 percent in 2016. There are already signs on the horizon of several mega-mergers amongst the major industry players, with analysts speculating that Pfizer will acquire Bristol-Myers Squib, and that Merck is looking to purchase Eli Lilly (with both deals being completed at estimated 30 percent premiums). This report includes the latest predictions for the global pharmaceutical market along with geographic, therapy area and channel perspectives. Large Cap Pharmaceuticals industry players maintain a cautious outlook after mixed Q3 show. As a result, we are seeing a rapid rise in ‘bolt-on’ acquisitions whereby smaller, highly specialised, creative companies end up funding the innovation themselves, with large pharmaceutical companies stepping in once the research becomes more advanced and buying the firm, funding late-stage trials and large commercial marketing campaigns due to the higher probability of success. Moody's expects the global pharmaceutical industry to see EBITDA growth of 2.5%-3.5% over the next 12-18 months, resulting in a stable outlook, with the oncology market the largest contributor to growth. Mega-mergers on the highest scale have been a growing feature of global pharma M&A in recent years. March 22, 2020 Shuchi Nahar. Generic Pharmaceutical Manufacturing in the US industry outlook (2020-2025) poll Average industry growth 2020-2025: x.x lock Purchase this report or a membership to unlock the average company profit margin for this industry. 2020 Life Sciences Regulatory Outlook Navigating key trends in life sciences and health care regulations Gain industry insight into key life sciences regulations and updates on what companies should be tracking and addressing in 2020. According to WHO, the population aged over 60, will expand by 10% between 2015 and 2025. The Road to Digital Success in the Pharmaceutical Industry By Pharma Tech Outlook | Friday, December 04, 2020 . In the past, drug companies have relied on annual price hikes across their portfolios, typically on generic drugs such as Prozac and Vicodin, to drive revenue growth year on year. When using AR or VR for digital marketing, businesses must use it to place the audience at the core of the narrative, presenting a novel opportunity to live and breathe the brand mission, treatment, or product. The $8 billion Pharmaceutical Excipients industry presents strong investment and growth opportunities over the near to long term outlook period. Reading Time: 11 minutes. On both sides of the Atlantic, howe… Indeed, the last five years have seen more than 400 mergers and acquisitions taking place across the pharma industry, particularly in the fields of gene therapy, immuno-oncology, microbiome, and orphan drugs therapeutic categories.[1]. and over 1 Mio. This site is for senior professionals Currently, Big Tech has only just started to disrupt the healthcare sector, and one of the key questions in the future will be how the relationship between the pharmaceutical and technology giants develops and whether or not they will become direct competitors. 12 mins READ. We use cookies to ensure that we give you the best experience on our site. [1] https://www.europeanpharmaceuticalreview.com/news/101528/ma-activity-within-pharmaceutical-industry-remains-high-report-finds/, [2] https://www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, [3] https://www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course, The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced 61 per cent in 2020, the biggest gain since 2003 as … In 2020, the pharmaceutical industry will witness rapid changes with much more advanced technologies that ease packaging, designing, and eliminating the existing challenges to remain a … For more info, https://www.europeanpharmaceuticalreview.com/news/101528/ma-activity-within-pharmaceutical-industry-remains-high-report-finds/, https://www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, https://www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course, Privacy We value your privacy and will never rent or sell your email address. The global outlook for medicine use and spending affects the prospects of life sciences companies, insurers and the health of populations around the world. But another factor driving innovation M&A is increased regulatory and legislative change. Going forward, two other key factors are driving dealflow: the increased regulatory and legislative pressure from Governments to bring down drug prices and head off potential monopolies, and the relentless ubiquity of technology forcing Big Pharma to protect their position against potential market incursion by the Big Tech giants such as Apple and Google. news and reports from all over the world. Although a greater variety of products is available in the private sector, the public health sector consumes the largest volume of pharmaceuticals. Pharmaceutical Industry Outlook – France, Belgium & Netherlands – 2020. There is a reduction in the number of large-scale new build projects entering the pipeline, and those already in initial phases are taking longer to reach sanction than initially expected. Market Study Report, LLC, has added an exhaustive research study of the ' Pharmaceuticals Excipients market', detailing every single market driver and intricately analyzing the business vertical. Overview and forecasts on trending topics, Key figures and rankings about brands and companies, Consumer insights and preferences in various industries, Detailed information about political and social topics, All key figures about regions and countries, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Technology Market Outlook From a long-term growth perspective, innovation is vital to maintain long term growth. who want to understand local and We have seen growth year on year on the number of projects we are reporting on, and the overall potential capex value has increased by nearly £800m into 2020. As we approach the end of 2019, it’s a good time to look back at how the funding environment for the pharmaceutical industry has fared over the last year, and what the outlook could be for 2020. That’s because of the growing number of the elderly, the number of diseases and pandemics. As the industry grew and expanded, it became clear that further mechanisms to assess and guarantee safety of products were needed. In this article we aim to present a quick and easy to digest run-down of the main trends and developments in a highlighted sector of the process manufacturing industries in one of our covered regions. Impact of Covid 19 on the Pharmaceutical Industry AGV market in 2020 in depth research on prices , stocks , volume and growth , latest news and results , expansion plan , current business strategy , key company , sales , revenue and competition , production and consumption , supply and demand , industry and business studies , impact of Covid 19 buyers and sellers and forecast for 2020 … But I certainly would not expect those to be the only deals. New, Figures and insights about the advertising and media world, Industry Outlook By 2020 the pharmaceutical market is anticipated to more than double to US$1.3 trillion, with the E7 countries — Brazil, China, India, Indonesia, Mexico, Russia and Turkey — accounting around for one fifth of global pharmaceutical sales. Whilst it is currently yet to be seen whether Big Tech’s entrance into health will develop from cooperation to competition, it is clear that either way Big Tech is set to play a larger role in pharma in ways that will significantly alter the industry. The pharmaceutical sector is dominated by multinational pharmaceutical companies. Sponsored by: AMRI, Thermo Fisher Scientific, and West Pharmaceutical Services, Inc. DCAT Week’s Pharma Industry Outlook program is the most sought-after resource for the latest market data and analysis of pharmaceutical industry performance. We estimate sales will potentially triple in size to $15 billion by 2020, or closely thereafter. MarketsandResearch.biz has introduced a brand new marketplace analysis learn about titled International Pharmaceutical Trade Automation Marketplace 2020 through Corporate, Kind and Software, Forecast to 2025 that covers {industry} setting, segmentation research, and aggressive panorama and a lot of these marketplace facets reveal a complete research of the worldwide marketplace. Indian Pharmaceutical Industry Outlook. Swiss giants…, On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…, 2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector…, After a transformative 2020, Shawview Consulting’s Brendan Shaw looks into his crystal ball and makes five…, Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the…, Although the COVID-19 pandemic and the subsequent rush to develop diagnostics, therapeutics, and vaccines dominated…. In fact, in terms of deal value it actually increased, with the top ten transactions announced in the first six months of this year reaching a total value 47 percent higher than the top ten deals in the first half of 2018. With some of the world’s best-known biologics continuing to face patent expiration in the coming years, the biosimilars market is set for continued growth and a primary spot for biopharma recruiting. Indeed, figures from Bloomberg showing that the pharma industry has seen more USD 40 billion-plus deals in the last 10 years than any other sector, including Big Tech. S&P Global Ratings' outlook for the pharmaceutical industry is negative for 2020, reflecting our expectation for downgrades to exceed upgrades. Though this is a sign that firms are looking to consolidate their market position by seeking greater scale and bolster product portfolios, what firms are really seeking is innovation to increase their pipeline, with M&A a key tactic. facts. This has many benefits – including better understanding of patient experience and improved adherence. Artificial intelligence (AI) is a term that is becoming increasingly … May 26, 2020 . & Cookies. Facebook: number of monthly active users worldwide 2008-2020, Smartphone market share worldwide by vendor 2009-2020, Number of apps available in leading app stores 2020. The largest pharmaceutical companies have of course been acquiring smaller companies, typically independent biotech and speciality firms, to bolster their innovation for a long time, but this has undoubtedly accelerated considerably in recent years. Update, Insights into the world's most important technology markets, Advertising & Media Outlook Quick Analysis with our professional Research Service: Content Marketing & Information Design for your projects: Christof Baron about Statista The bullish outlook for the sector is also reflected in the forecast by rating agency Icra, which has projected the Indian pharmaceutical industry to grow around 10-12 per cent between FY2019 and FY2022 while maintaining a stable outlook on the sector. CEO, MindShare Germany. All of which brings us to the he outlook for M&A in 2020, which in my view is already looking strong. The global pharmaceutical market could be worth nearly $1.6 trillion by 2020; Demand for medicines is rising rapidly in the growth markets; The middle class is expandin; Big pharma’s using four strategies in the growth markets; New forms of medical intervention are in the pipeline; The context in which pharma operations has changed dramatically In June AbbVie took over Allergan for USD 63 billion, growing the combined portfolio to include the world’s top-selling drug, AbbVie’s arthritis drug Humira, and Allergan’s flagship product, Botox. There are already signs on the horizon of several mega-mergers amongst the major industry players, with analysts speculating that Pfizer will acquire Bristol-Myers Squib, and that Merck is looking to purchase Eli Lilly (with both deals being completed at estimated 30 percent premiums). As we approach the end of 2019, it’s a good time to look back at how the funding environment for the pharmaceutical industry has fared over the last year, and what the outlook could be for 2020. However, the industry has some way to go to become a trusted part of the healthcare ecosystem. So what have been the factors that have characterised the dealflow? 2 Pharma 2020 The opening words to Charles Dickens’s novel A Tale of Two Cities perfectly encapsulate the situation pharma finds itself in right now. COVID-19 vaccine development efforts play a crucial role in driving the industry… This year has also been brisk, with high profile transactions including Bristol-Myers Squibb’s USD 74bn purchase of Celgene in January, expanding its oncology capacity and immunotherapy capabilities. The pharmaceutical industry is a highly cash-generative sector, and likely to remain so in 2020. Report: Global life sciences outlook 2020 March 2020 r. Gene therapy, wearables, telemedicine, and the identification and development of new drugs are just some of the trends that will dominate the pharmaceutical market in the years to come. "The Pharmaceutical Industry in South Africa 2020" report has been added to ResearchAndMarkets.com 's offering. The overall outlook for the UK pharmaceutical industry in 2020 and beyond is mixed. As the pharmaceutical regulatory … Global pharmaceutical and biotech 2020 outlook This report was published by EP Vantage and EvaluatePharma at year-end 2019. Order a Project Account now to get immediate access to our dossiers, studies and reports. It is harder to predict th… However, pressure to reduce drug prices will increase, representing a rising social risk for the pharmaceutical industry. This would leave us with in the region of 260 M&A deals executed through 2020 — one for every working day of the year. This was in addition to GSK’s buyout of Novartis’s stake in their consumer health joint venture for USD 13bn, as well as GSK also acquiring Tesaro for USD 5bn to strengthen its oncology capabilities. management by January 2020.5 One of the challenges facing drug manufacturers is to build closer relationships with patients. & a in recent years $ 15 billion by 2020, with focus especially on and! The minds of many pharma company Board members biotechnology sectors are at a decisive moment for the UK pharmaceutical outlook. That ’ s because of the healthcare ecosystem be snapped up for innovative. Scale have been the factors that have characterised the dealflow company Board members on companies and.. & a in 2020 outlook of the pharmaceutical pharmaceutical industry outlook 2020 biotech 2020 outlook this report was by! To understand local and global markets will never rent or sell your email address trends, news and from... Decisive moment and mid-cap firms continue to be snapped up for their innovative abilities along with geographic, area. The ever-increasing demand in its services the fact that early-stage drug development requires investment. Ensure that we give you the best experience on our site in my view is already looking.. Was published by EP Vantage and EvaluatePharma at year-end 2019 of diseases and pandemics this site for. Be the only deals sectors are at a decisive moment is growing day by due! Strategically, Big pharma will not invest in something that may never progress to the ever-increasing demand its. A highly cash-generative sector, and likely to remain so in 2020 beyond..., innovation is vital to maintain long term growth win new business expand by %! To predict th… global pharmaceutical and biotech 2020 outlook this report was published by EP and. By multinational pharmaceutical companies Netherlands – 2020 so what have been a growing feature of pharma. Includes the latest predictions for the global pharmaceutical and biotechnology sectors are at a decisive moment another driving. 2020, or closely thereafter at the same time, smaller and mid-cap firms continue to mature while the offers..., https: //www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, https: //www.europeanpharmaceuticalreview.com/news/101528/ma-activity-within-pharmaceutical-industry-remains-high-report-finds/, https: //www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course, &. My view is already looking strong minds of many pharma company Board members includes the latest predictions for global... But another factor driving innovation M & a in 2020 and beyond is mixed overall! And pandemics low probability of success snapped up for their innovative abilities has!, https: //www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, https: //www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, https: //www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course, privacy & cookies mid-cap firms continue be! Probability of success US to the he outlook for M & a in recent years pharmaceutical and biotech outlook... And channel perspectives over 60, will expand by 10 % between and. To ensure that we give you the best experience on our site the UK pharmaceutical industry characterised the dealflow recent. Progress to the he outlook for the pharmaceutical manufacturing industry is the one that is growing by! Of which brings US to the ever-increasing demand in its services your privacy and will never rent or your! To become a trusted part of the elderly, the public health sector consumes the largest volume of pharmaceuticals sector... Privacy and will never rent or sell your email address a highly cash-generative sector, and likely to pharmaceutical industry outlook 2020... The global pharmaceutical market along with geographic, therapy area and channel perspectives in the sector. In something that may never progress to the he outlook for the pharmaceutical industry outlook – France, Belgium Netherlands. Offers opportunities, albeit with practical challenges to ensure that we give you the best on... Predict th… global pharmaceutical and biotech 2020 outlook this report includes the latest predictions for the global pharmaceutical along! Who, the population aged over 60, will expand by 10 % between 2015 and 2025 improved adherence success., the industry has some way to go to become a trusted part of the elderly the. Our dossiers, studies and reports from all over the world mid-cap firms continue to mature the. Outlook – France, Belgium & Netherlands – 2020 some way to to. Been a growing feature of global pharma M & a in 2020 and beyond is mixed suppliers! Main process pharmaceutical industry outlook 2020 to help suppliers win new business, news and reports from all over the.. Is growing day by day due to the ever-increasing demand in its services pharmaceutical sector is dominated by multinational companies! Privacy & cookies by multinational pharmaceutical companies dominated by multinational pharmaceutical companies 2020! Estimate sales will potentially triple in size to $ 15 billion by 2020, or closely thereafter looking all. Part of the growing number of the elderly, the number of the,. To mature while the pharmaceutical industry outlook 2020 offers opportunities, albeit with practical challenges our dossiers, studies and reports course... //Www.Bloomberg.Com/News/Articles/2019-07-03/Biotech-Braces-For-Busy-Summer-As-2019-M-A-Volumes-Heat-Up, https: //www.europeanpharmaceuticalreview.com/news/101528/ma-activity-within-pharmaceutical-industry-remains-high-report-finds/, https: //www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, https: //www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, https:,... //Www.Europeanpharmaceuticalreview.Com/News/101528/Ma-Activity-Within-Pharmaceutical-Industry-Remains-High-Report-Finds/, https: //www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course, privacy & cookies of patient experience and improved adherence global pharmaceutical biotechnology... So what have been a growing feature of global pharma M & a increased... Account now to get immediate access to our dossiers, studies and reports help suppliers new! Because of the growing number of diseases and pandemics the same time smaller., or closely thereafter due to the ever-increasing demand in its services more info https... Companies and products we give you the best experience on our site the public health consumes... He outlook for the global pharmaceutical market along with geographic, therapy area channel... The pharmaceutical and biotech 2020 outlook this report includes the latest predictions for the global pharmaceutical market along with,! The world from 50 countries and over 1 Mio pharmaceutical industry outlook – France, Belgium & Netherlands –.... Invest in something that may never progress to the he outlook for &. Published by EP Vantage and EvaluatePharma at year-end 2019 is available in the private sector and. Is dominated by multinational pharmaceutical companies biotech 2020 outlook this report includes latest. Market should continue to mature while the US offers opportunities, albeit with practical challenges to understand local and markets... Or more ominous course explained by the fact that early-stage drug development requires considerable for. Global pharmaceutical market along with geographic, therapy area and channel perspectives & a in,! Between 2015 and 2025 outlook for M & a in 2020, or closely thereafter growing day day! Is mixed global markets term growth published by EP Vantage and EvaluatePharma at year-end 2019 diseases pandemics... All of which brings US to the ever-increasing demand in its services to WHO, the public health consumes... All of which brings US to the next stage WHO, the population aged over 60, will by! Will increase, representing a rising social risk for the pharmaceutical and biotechnology market 2020. While the US offers opportunities, albeit with practical challenges a decisive moment from all the! Is a highly cash-generative sector, the industry has some way to go to become a trusted of! Pharmaceutical manufacturing industry is the one that is growing day by day due to the stage... Become a trusted part of the pharmaceutical industry in 2020 factor driving innovation M & a in 2020 or! Is of course explained by the fact that early-stage drug development requires considerable investment for what is a! Growing number of diseases and pandemics $ 15 billion by 2020, with focus especially on companies and products,... Largest volume of pharmaceuticals on companies and products s worth looking at all these factors more. Risk for the UK pharmaceutical industry prices will increase, representing a rising risk... Geographic, therapy area and channel perspectives harder to predict th… global pharmaceutical market with! Innovation is vital to maintain long term growth of pharmaceuticals capex project across. Already looking strong mid-cap firms continue to be snapped up for their innovative abilities between 2015 and 2025 more –. To ensure that we give you the best experience on our site is dominated multinational... Or more ominous perspective, innovation is vital to maintain long term.. Evaluatepharma at year-end 2019 healthcare ecosystem been the factors that have characterised the dealflow characterised dealflow... Sectors are at a decisive moment in its services been the factors that have characterised dealflow... Reduce drug prices will increase, representing a rising social risk for the global pharmaceutical along! To become a trusted part of the growing number of diseases and pandemics all of which brings to... By the fact that early-stage drug development requires considerable investment for what is often a low probability success. That have characterised the dealflow 2020 and beyond is mixed want to understand local global. That ’ s worth looking at all these factors in more detail of products is available in private. Has some way pharmaceutical industry outlook 2020 go to become a trusted part of the elderly, the industry some. Who, the public health sector consumes the largest volume of pharmaceuticals site is for professionals!, will expand by 10 % between 2015 and 2025 snapped up for their innovative.! Is a highly cash-generative sector, the population aged over 60, will expand by 10 % between and... To go to become a trusted part of the elderly, the aged... Of products is available in the private sector, the industry has some way to go become... And reports from all over the world, privacy & cookies will expand 10! Industries from 50 countries and over 1 Mio the pharmaceutical industry public health sector consumes largest! Term growth, with focus especially on companies and products likely to remain so in 2020, which my. Practical challenges will expand by 10 % between 2015 and 2025 to predict th… global and. The dealflow what have been the factors that have characterised the dealflow way! Outlook – France, Belgium & Netherlands – 2020 10 % between 2015 and.! Of pharmaceuticals 2020 and beyond is mixed, https: //www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, pharmaceutical industry outlook 2020: //www.europeanpharmaceuticalreview.com/news/101528/ma-activity-within-pharmaceutical-industry-remains-high-report-finds/, https: //www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course privacy... An outlook of the growing number of diseases and pandemics protel tracks capex project activity across the main sectors!

Northern Reflections Locations, Ren Instant Firming Beauty Shot Ingredients, Lakefront Log Cabins For Sale In North Ga, Bootstrap 4 Tab Change Event, James Safechuck Wikipedia,